Vanguard Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $163M | Sell |
13,828,355
-75,380
| -0.5% | -$813K | ﹤0.01% | 1652 |
|
|
2025
Q3 | $107M | Sell |
13,903,735
-227,026
| -2% | -$1.59M | ﹤0.01% | 1828 |
|
|
2025
Q2 | $103M | Sell |
14,130,761
-126,355
| -0.9% | -$1.02M | ﹤0.01% | 1819 |
|
|
2025
Q1 | $135M | Buy |
14,257,116
+17,229
| +0.1% | +$215K | ﹤0.01% | 1653 |
|
|
2024
Q4 | $235M | Buy |
14,239,887
+195,793
| +1% | +$3.04M | ﹤0.01% | 1472 |
|
|
2024
Q3 | $207M | Sell |
14,044,094
-77,396
| -0.5% | -$1.21M | ﹤0.01% | 1527 |
|
|
2024
Q2 | $196M | Sell |
14,121,490
-89,529
| -0.6% | -$1.27M | ﹤0.01% | 1510 |
|
|
2024
Q1 | $223M | Buy |
14,211,019
+41,354
| +0.3% | +$638K | ﹤0.01% | 1450 |
|
|
2023
Q4 | $229M | Sell |
14,169,665
-146,536
| -1% | -$2.4M | 0.01% | 1425 |
|
|
2023
Q3 | $176M | Sell |
14,316,201
-324,613
| -2% | -$4.83M | ﹤0.01% | 1495 |
|
|
2023
Q2 | $235M | Buy |
14,640,814
+770,257
| +6% | +$12.7M | 0.01% | 1385 |
|
|
2023
Q1 | $241M | Buy |
13,870,557
+195,812
| +1% | +$2.79M | 0.01% | 1353 |
|
|
2022
Q4 | $126M | Buy |
13,674,745
+500,037
| +4% | +$4.66M | ﹤0.01% | 1673 |
|
|
2022
Q3 | $113M | Sell |
13,174,708
-141,693
| -1% | -$1.41M | ﹤0.01% | 1714 |
|
|
2022
Q2 | $109M | Buy |
13,316,401
+345,898
| +3% | +$3.3M | ﹤0.01% | 1766 |
|
|
2022
Q1 | $158M | Buy |
12,970,503
+113,534
| +0.9% | +$2.39M | ﹤0.01% | 1693 |
|
|
2021
Q4 | $439M | Buy |
12,856,969
+186,607
| +1% | +$7.31M | 0.01% | 1085 |
|
|
2021
Q3 | $611M | Buy |
12,670,362
+472,802
| +4% | +$21.9M | 0.02% | 857 |
|
|
2021
Q2 | $551M | Buy |
12,197,560
+168,921
| +1% | +$7.48M | 0.01% | 936 |
|
|
2021
Q1 | $580M | Buy |
12,028,639
+861,061
| +8% | +$44.8M | 0.02% | 868 |
|
|
2020
Q4 | $601M | Buy |
11,167,578
+284,828
| +3% | +$12.9M | 0.02% | 787 |
|
|
2020
Q3 | $401M | Sell |
10,882,750
-357,852
| -3% | -$13.3M | 0.01% | 866 |
|
|
2020
Q2 | $348M | Buy |
11,240,602
+462,957
| +4% | +$12.8M | 0.01% | 937 |
|
|
2020
Q1 | $298M | Buy |
10,777,645
+264,642
| +3% | +$7.93M | 0.01% | 897 |
|
|
2019
Q4 | $308M | Buy |
10,513,003
+81,178
| +0.8% | +$1.93M | 0.01% | 1112 |
|
|
2019
Q3 | $199M | Buy |
10,431,825
+2,258,111
| +28% | +$53M | 0.01% | 1334 |
|
|
2019
Q2 | $179M | Buy |
8,173,714
+2,401,227
| +42% | +$52.7M | 0.01% | 1427 |
|
|
2019
Q1 | $118M | Buy |
5,772,487
+1,678,162
| +41% | +$29.2M | ﹤0.01% | 1660 |
|
|
2018
Q4 | $51.6M | Buy |
4,094,325
+254,684
| +7% | +$3.8M | ﹤0.01% | 2008 |
|
|
2018
Q3 | $58.9M | Buy |
3,839,641
+743,245
| +24% | +$10.3M | ﹤0.01% | 2067 |
|
|
2018
Q2 | $40.6M | Buy |
3,096,396
+36,581
| +1% | +$403K | ﹤0.01% | 2236 |
|
|
2018
Q1 | $25M | Buy |
3,059,815
+104,112
| +4% | +$843K | ﹤0.01% | 2407 |
|
|
2017
Q4 | $26.2M | Buy |
2,955,703
+68,629
| +2% | +$633K | ﹤0.01% | 2376 |
|
|
2017
Q3 | $32.1M | Buy |
2,887,074
+162,471
| +6% | +$1.58M | ﹤0.01% | 2274 |
|
|
2017
Q2 | $24.4M | Buy |
2,724,603
+44,820
| +2% | +$356K | ﹤0.01% | 2371 |
|
|
2017
Q1 | $21.1M | Buy |
2,679,783
+176,691
| +7% | +$1.44M | ﹤0.01% | 2418 |
|
|
2016
Q4 | $21.5M | Buy |
2,503,092
+238,446
| +11% | +$2.04M | ﹤0.01% | 2393 |
|
|
2016
Q3 | $18.6M | Buy |
2,264,646
+134,133
| +6% | +$1.13M | ﹤0.01% | 2392 |
|
|
2016
Q2 | $17.1M | Buy |
2,130,513
+441,119
| +26% | +$3.54M | ﹤0.01% | 2396 |
|
|
2016
Q1 | $11.4M | Buy |
1,689,394
+93,298
| +6% | +$614K | ﹤0.01% | 2544 |
|
|
2015
Q4 | $12.6M | Buy |
1,596,096
+23,602
| +2% | +$173K | ﹤0.01% | 2515 |
|
|
2015
Q3 | $9.01M | Buy |
1,572,494
+138,715
| +10% | +$859K | ﹤0.01% | 2662 |
|
|
2015
Q2 | $7.76M | Buy |
1,433,779
+122,998
| +9% | +$634K | ﹤0.01% | 2806 |
|
|
2015
Q1 | $6.12M | Buy |
1,310,781
+115,997
| +10% | +$504K | ﹤0.01% | 2895 |
|
|
2014
Q4 | $4.98M | Buy |
1,194,784
+26,569
| +2% | +$122K | ﹤0.01% | 2904 |
|
|
2014
Q3 | $6.09M | Buy |
1,168,215
+385,466
| +49% | +$1.98M | ﹤0.01% | 2729 |
|
|
2014
Q2 | $2.6M | Sell |
782,749
-50,129
| -6% | -$167K | ﹤0.01% | 3145 |
|
|
2014
Q1 | $2.89M | Buy |
832,878
+150,085
| +22% | +$562K | ﹤0.01% | 3063 |
|
|
2013
Q4 | $2.47M | Buy |
682,793
+4,492
| +0.7% | +$15.6K | ﹤0.01% | 3107 |
|
|
2013
Q3 | $2.04M | Buy |
678,301
+288,652
| +74% | +$813K | ﹤0.01% | 3125 |
|
|
2013
Q2 | $1.55M | Buy |
+389,649
| New | +$1.49M | ﹤0.01% | 3156 |
|
Other funds holding NEO
FLAM
GF
B
NAMI
Vanguard Group's NEO Position: Q4 2025 in Review
Vanguard Group reduced its NeoGenomics (NEO) stake by 0.54% in Q4 2025, selling an estimated $813K and leaving 13,828,355 shares worth $163M. The position accounts for ﹤0.01% of the portfolio, ranked #1652.
Vanguard Group first reported a position in NEO in Q2 2013 and has held it in 51 quarters since. The position peaked at $611M in Q3 2021. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.
- Vanguard Group held 13,828,355 shares of NeoGenomics worth $163M as of Q4 2025.
- Vanguard Group sold 75,380 NeoGenomics shares in Q4 2025, an estimated $813K.
- NeoGenomics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1652 holding.
- Vanguard Group first reported a position in NeoGenomics in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's NeoGenomics position peaked at $611M in Q3 2021.
- 256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.